The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000257.4(MYH7):c.1208G>A (p.Arg403Gln)

CA010365

14087 (ClinVar)

Gene: MYH7 (HGNC:4625)
Condition: hypertrophic cardiomyopathy (MONDO:0005045)
Inheritance Mode: Autosomal dominant inheritance
UUID: ae1c8298-2afe-4242-9a38-eea990986d41
Approved on: 2016-12-15
Published on: 2018-11-16

HGVS expressions

NM_000257.4(MYH7):c.1208G>A (p.Arg403Gln)
NM_000257.4:c.1208G>A
NC_000014.9:g.23429278C>T
CM000676.2:g.23429278C>T
NC_000014.8:g.23898487C>T
CM000676.1:g.23898487C>T
NC_000014.7:g.22968327C>T
NG_007884.1:g.11384G>A
ENST00000355349.4:c.1208G>A
ENST00000355349.3:c.1208G>A
NM_000257.3:c.1208G>A
More

Pathogenic

Met criteria codes 7
PS3 PP1_Strong PS4 PP3 PM1 PM5 PM2

Evidence Links 10

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Cardiomyopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MYH7 Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cardiomyopathy VCEP
The c.1208G>A (p.Arg403Gln) variant in MYH7 has been reported in >30 individuals with hypertrophic cardiomyopathy and segregated with disease in >30 affected family members (PS4 and PP1_Strong; PMID:1638703; PMID:1975517; PMID:7789380; PMID:12975413; PMID:24268868; PMID:10725281; PMID:20800588; PMID:12707239; PMID:27532257; AGCMC Sydney ClinVar SCV000692503.1; Invitae ClinVar SCV000253815.4; Partners LMM ClinVar SCV000059359.5; SHaRe consortium, PMID: 30297972). Mouse model indicates that this variant disrupts the function of MYH7 and leads to a phenotype consistent with HCM (PS3: PMID:8614836). This variant was absent from large population studies (PM2; http://exac.broadinstitute.org). This variant lies in the head region of the protein (aa 181-937) and missense variants in this region are statistically more likely to be disease-associated (PM1; PMID:27532257). Computational prediction tools and conservation analysis suggest that this variant may impact the protein (PP3). A different pathogenic missense variant has been previously identified at this codon which may indicate that this residue is critical to the function of the protein (PM5; c.1207C>T (p.Arg403Trp) - Variation ID 14102). In summary, this variant meets criteria to be classified as pathogenic for hypertrophic cardiomyopathy in an autosomal dominant manner. MYH7-specific ACMG/AMP criteria applied (PMID:29300372): PS3; PS4; PP1_ Strong; PM1; PM2; PM5; PP3
Met criteria codes
PS3
In vivo mouse model with R403Q. Homozygous mice died 7 days after birth, heterozygous mice survived 1 year but had cardiac histopathology and dysfunction resembling HCM.

PP1_Strong
>30 segregations (including ClinVar SCV000692503.1; ClinVar SCV000059359.5)

PS4
>25 probands with HCM (including data from: ClinVar SCV000692503.1; ClinVar SCV000253815.4; ClinVar SCV000059359.5; SHaRe data)

PP3
Tools predict damaging
PM1
Variants in head region of the protein (aa 181-937) are statistically more likely to be disease-associated

PM5
c.1207C>T (p.Arg403Trp) - Variation ID 14102 - Pathogenic by ClinGen Expert Panel
PM2
Absent from ExAC
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.